Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Reproductive Biology and Endocrinology : RB&E|June 23, 2011
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patientsErnesto Bosch, Diego Ezcurra
Reproductive Biology and Endocrinology : RB&E|October 5, 2014
A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technologyDiego Ezcurra, Peter Humaidan
Reproductive Biology and Endocrinology : RB&E|April 26, 2012
Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatmentKlaus Fiedler, Diego Ezcurra
Reproductive Biology and Endocrinology : RB&E|December 30, 2014
Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropinsClaus Y Andersen, Diego Ezcurra
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2009
GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technologyIlan Tur-Kaspa, Diego Ezcurra
Reproductive Biology and Endocrinology : RB&E|February 8, 2012
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocolsCarlo Alviggi, Peter Humaidan, Diego Ezcurra
Reproductive Biology and Endocrinology : RB&E|September 18, 2010
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysisPhilippe Lehert, Joan C Schertz, Diego Ezcurra
Expert Review of Endocrinology & Metabolism|February 21, 2019
Ovarian stimulation protocols in assisted reproductive technology: an updateColin M Howles, Diego Ezcurra, Roy Homburg
Reproductive Biomedicine Online|December 17, 2008
The HOPE Registry: first US registry for oocyte cryopreservationDiego Ezcurra, Jennifer Rangnow, Maryellen Craig, et al.
Reproductive Biology and Endocrinology : RB&E|May 29, 2009
The Human Oocyte Preservation Experience (HOPE) a phase IV, prospective, multicenter, observational oocyte cryopreservation registryDiego Ezcurra, Jennifer Rangnow, Maryellen Craig, et al.
Pageof 2